Lv1
10 积分 2024-04-28 加入
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
12天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
23天前
已完结
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
25天前
已完结
皖公网安备34019202002308
